Catherine Levene - 01 Dec 2021 Form 4 Insider Report for Meredith Holdings Corp

Signature
/s/ Andrew Kane, by Power of Attorney for Catherine Levene
Issuer symbol
N/A
Transactions as of
01 Dec 2021
Net transactions value
$0
Form type
4
Filing time
03 Dec 2021, 14:06:04 UTC
Previous filing
12 Nov 2021
Next filing
07 Nov 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction Common Stock ($1 par value) Disposed to Issuer -2,052 -100% 0 01 Dec 2021 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction Restricted Stock Units Award +41,925 41,925 01 Dec 2021 Common Stock ($1 par value) 41,925 Direct F3, F4, F5
transaction Restricted Stock Units Disposed to Issuer -41,925 -100% 0 01 Dec 2021 Common Stock ($1 par value) 41,925 Direct F3, F5
transaction Non-Qualified Stock Option (right to buy) Award +4,000 4,000 01 Dec 2021 Common Stock ($1 par value) 4,000 $38.08 Direct F4, F6
transaction Non-Qualified Stock Option (right to buy) Disposed to Issuer -4,000 -100% 0 01 Dec 2021 Common Stock ($1 par value) 4,000 $38.08 Direct F6
transaction Non-Qualified Stock Option (right to buy) Award +6,550 6,550 01 Dec 2021 Common Stock ($1 par value) 6,550 $26.37 Direct F4, F6
transaction Non-Qualified Stock Option (right to buy) Disposed to Issuer -6,550 -100% 0 01 Dec 2021 Common Stock ($1 par value) 6,550 $26.37 Direct F6
transaction Non-Qualified Stock Option (right to buy) Award +12,025 12,025 01 Dec 2021 Common Stock ($1 par value) 12,025 $10.15 Direct F4, F6
transaction Non-Qualified Stock Option (right to buy) Disposed to Issuer -12,025 -100% 0 01 Dec 2021 Common Stock ($1 par value) 12,025 $10.15 Direct F6
transaction Non-Qualified Stock Option (right to buy) Award +12,975 12,975 01 Dec 2021 Common Stock ($1 par value) 12,975 $15.66 Direct F4, F6
transaction Non-Qualified Stock Option (right to buy) Disposed to Issuer -12,975 -100% 0 01 Dec 2021 Common Stock ($1 par value) 12,975 $15.66 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Catherine Levene is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 The Reporting Person received these shares in the previously announced spin-off of Meredith Corporation's digital and magazine segments and corporate operations (the "Spin-Off"), described in the issuer's Registration Statement on Form 10 filed with the Securities and Exchange Commission on November 9, 2021 (the "Form 10"). The Spin-Off involved the pro rata distribution of shares of the issuer by Meredith Corporation to its shareholders on a one-for-one basis and the Spin-Off was consummated on December 1, 2021. The Reporting Person's receipt of such shares in the Spin-Off was exempt from reporting pursuant to Rule 16a-9.
F2 In connection with the closing of the previously announced acquisition of the issuer by Dotdash Media Inc. (the "Merger") and as described in the Current Report on Form 8-K filed by Meredith Corporation, which was previously the issuer's parent company, on October 6, 2021 (the "8-K"), each share of Common Stock was exchanged for $42.18 in cash per share.
F3 In connection with the Merger and as described in the 8-K, these awards were canceled in exchange for $42.18 in cash per share.
F4 In connection with the Spin-Off and as described in the Form 10, the Reporting Person received this award in partial consideration for the cancellation of an equity award of Meredith Corporation previously held by the Reporting Person.
F5 Pursuant to their original terms, the Restricted Stock Units were convertible to Common Stock on a one-for-one basis upon the completion of a three-year vesting period.
F6 In connection with the Merger and as described in the 8-K, this option was canceled in exchange for a cash amount equal to the excess, if any, of $42.18 per share less the exercise price.